| 期刊全称 | Current Signal Transduction Therapy |
|---|
| 期刊缩写 | CURR SIGNAL TRANSD T |
|---|
| 涉及主题 | 生物医学遗传学化学内科学生物化学计算机科学细胞生物学癌症研究物理心理学信号转导基因癌症病理 |
|---|
| 期刊介绍 | In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery. |
|---|
| 期刊ISSN | print: 1574-3624 on-line: 2212-389 |
|---|
| 历年影响因子 | | 2024年 | 2023年 | 2022年 | 2021年 | 2020年 | 2019年 | 2018年 | 2017年 |
|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|---|
| 历年发表/被引量 | | 年份 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| 发表量 | 18 | 20 | 24 | 19 | 21 | 19 | 17 | 41 | 58 | 13 | 24 | 48 | | 被引量 | 0 | 6 | 23 | 16 | 32 | 52 | 86 | 137 | 246 | 34 | 54 | 137 |
|
|---|
| h-Index | 15 |
|---|
| 自引率 | N.A. |
|---|
| 涉及的研究领域 | 医学-药学 |
|---|
| 中科院2025年分区 ? | |
|---|
| WOS期刊分区 | |
|---|
| 期刊主页 | http://benthamscience.com/journal/index.php?journalID=cstt |
|---|
| 投稿网址 | http://benthamscience.com/journal/authors-guidelines.php?journalID=cstt#top |
|---|
| 出版商 | Bentham Science Publishers B.V. |
|---|
| 出版国家(地区) | U ARAB EMIRATES |
|---|
| 出版周期 | Tri-annual |
|---|
| 每年出版文章数 | 19 |
|---|
| Gold OA文章占比 | 0.00% |
|---|
原创研究文献占比 (排除综述) | 0.00% |
|---|
| SCI收录类型 | Scopus (CiteScore) |
|---|
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-3624%5BISSN%5D |
|---|
| 平均审稿周期 | >12周,或约稿 |
|---|
| 平均录用比例 | 容易 |
|---|
| 相关链接 | 您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。 |
|---|